Multicentre randomised phase III study comparing the same dose and schedule of cisplatin plus the same schedule of vinorelbine or gemcitabine in advanced non-small cell lung cancer.
about
Optimal duration of chemotherapy for advanced non-small cell lung cancerOptimal duration of chemotherapy for advanced non-small cell lung cancerAn NQO1-initiated and p53-independent apoptotic pathway determines the anti-tumor effect of tanshinone IIA against non-small cell lung cancerVinorelbine/carboplatin vs gemcitabine/carboplatin in advanced NSCLC shows similar efficacy, but different impact of toxicity.Comparison of vinorelbine-Cisplatin with gemcitabine-Cisplatin in patients with advanced non-small cell lung cancer.Molecular imaging in therapeutic efficacy assessment of targeted therapy for nonsmall cell lung cancerCirculating miRNAs as new blood-based biomarkers for solid cancers.What is the role of maintenance therapy in the treatment of non-small cell lung cancer?Squamous Cell Carcinoma - Similarities and Differences among Anatomical Sites.A systematic review of the clinical effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer.Phase II study of axitinib with doublet chemotherapy in patients with advanced squamous non-small-cell lung cancerComparing effectiveness with efficacy: outcomes of palliative chemotherapy for non-small-cell lung cancer in routine practice.Epidermal Growth Factor Receptor Mutation (EGFR) Testing for Prediction of Response to EGFR-Targeting Tyrosine Kinase Inhibitor (TKI) Drugs in Patients with Advanced Non-Small-Cell Lung Cancer: An Evidence-Based AnalysisThe mechanisms of chansu in inducing efficient apoptosis in colon cancer cells.Vinorelbine for non-small cell lung cancer.Histology as a treatment effect modifier in advanced non-small cell lung cancer: a systematic review of the evidence.Maintenance therapy for advanced non-small-cell lung cancer: switch versus continuation.An evaluation of the pharmacokinetics and clinical use of vinorelbine for NSCLC treatment.Apoptosis induced by benzyl isothiocyanate in gefitinib-resistant lung cancer cells is associated with Akt/MAPK pathways and generation of reactive oxygen species.Mitogen-activated protein kinase mediates the apoptosis of highly metastatic human non-small cell lung cancer cells induced by isothiocyanates.Oral vinorelbine plus cisplatin versus pemetrexed plus cisplatin as first-line treatment of advanced non-squamous non-small-cell lung cancer: cost minimization analysis in 12 European countries.Meta-analysis of first-line therapies with maintenance regimens for advanced non-small-cell lung cancer (NSCLC) in molecularly and clinically selected populations.Is gemcitabine cost effective in cancer treatment?Which should be added to cisplatin for advanced non-small-cell lung cancer--vinorelbine or gemcitabine?Prospective assessment of XRCC3, XPD and Aurora kinase A single-nucleotide polymorphisms in advanced lung cancer.
P2860
Q24200970-2C8AAED3-B0DD-4085-B7F1-A910C0E5F812Q24242409-2E74E300-7430-45CD-B629-31EF642E4955Q28481620-4B1FC2EA-5D72-40BE-8CC6-6976A7B74B38Q33375704-FB3BBB7D-237B-4483-8E34-D9AAC4074C34Q33393287-30A76C76-8DA3-4648-8720-C894CCB61DBCQ34243500-0BA4908A-D761-419F-8F6A-02B100EA478CQ34331651-4EE678E2-80DE-4356-8761-B8F3B0597C1EQ35076269-E419DEF0-2E01-4742-8133-A9AD2C55BDA6Q35220347-65BEC518-B862-428C-8C38-085FD2087680Q35557605-B2BF77A3-86B1-4464-9CD9-F2A26F0F3125Q35584072-5883F40B-A2BC-46F1-83B5-C4281F671202Q35714504-08B3B7FE-38FE-4530-A04D-155AAD87211FQ36040002-443875BC-67BE-49D4-BD68-3A1C4FEA8B3AQ36931329-3F405FA8-9DC2-44BF-B49D-0165A2F9EBBBQ37720767-98A43332-92AB-48D2-B513-DF24130AEED0Q37908174-882B0358-E688-4459-BEEC-AD72F37D9151Q37992189-73EA6E7C-51CF-4E54-AC58-55A28648648AQ38109229-C9EDE72F-6E81-4DBF-9706-388DEC0DA01BQ39251248-E6AEE9C4-6E04-4851-9F04-78F73D9964DDQ39511845-3672B385-BB15-4FC4-99C5-FBB2E21C4055Q39737145-65B3E56B-84DE-4F55-A4AF-3F26D4DB243EQ41311492-8A313662-50D3-4901-A852-9F6B4078DEB3Q43042833-EDA25864-ED4D-4E62-A958-DC6AB51A86B3Q46787061-8B052F2C-5CAF-4496-81DF-2E8099A7AD7CQ54478536-17AA714F-4C8B-4314-90EF-2A7FC1C22A6D
P2860
Multicentre randomised phase III study comparing the same dose and schedule of cisplatin plus the same schedule of vinorelbine or gemcitabine in advanced non-small cell lung cancer.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Multicentre randomised phase I ...... ed non-small cell lung cancer.
@ast
Multicentre randomised phase I ...... ed non-small cell lung cancer.
@en
type
label
Multicentre randomised phase I ...... ed non-small cell lung cancer.
@ast
Multicentre randomised phase I ...... ed non-small cell lung cancer.
@en
prefLabel
Multicentre randomised phase I ...... ed non-small cell lung cancer.
@ast
Multicentre randomised phase I ...... ed non-small cell lung cancer.
@en
P2093
P1476
Multicentre randomised phase I ...... ced non-small cell lung cancer
@en
P2093
A Petralia
F Di Fabio
F Sperandi
M Guaraldi
P356
10.1016/J.EJCA.2004.08.029
P577
2005-01-01T00:00:00Z